コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ify reactive specimens for confirmation by a nucleic acid amplification test.
2 t results were resolved using an alternative nucleic acid amplification test.
3 There were two false positive results on nucleic acid amplification tests.
4 reatly expand the diagnostic applications of nucleic acid amplification tests.
5 (UU-2), and Trichomonas vaginalis (TV) using nucleic acid amplification tests.
6 other month were tested for M. genitalium by nucleic acid amplification testing.
7 in whom WNV infection was identified by WNV nucleic acid amplification testing.
8 ts and laboratory-based specimen pooling for nucleic acid amplification testing.
9 e compared to those from culture and the LCx nucleic acid amplification test (Abbott Industries, Abbo
10 rovide valid specimens for HPV testing using nucleic acid amplification tests, although a few cytolog
11 ,749 vulvovaginal-swab specimens with both a nucleic acid amplification test and a polymer conjugate-
12 true-negative or false-negative relative to nucleic acid amplification test and/or enzyme immunoassa
13 ine whether test performance measures of two nucleic acid amplification tests and a DNA probe were af
14 tive donations were confirmed by alternative nucleic acid amplification tests and IgM and IgG tests,
15 es and gaining in use are techniques such as nucleic acid amplification tests and mass spectroscopy t
17 genitalium coinfections were evaluated using nucleic acid amplification tests and were negative at 1
19 proaches to diagnosis remain inaccurate, and nucleic acid amplification tests are also compromised by
22 imens from women are suitable substrates for nucleic acid amplification tests, but enzyme immunoassay
23 ting areas of the clinical spectrum in which nucleic acid amplification tests can make an important c
24 In 10 new studies of asymptomatic patients, nucleic acid amplification tests demonstrated sensitivit
25 The Alere i strep A test is an isothermal nucleic acid amplification test designed to offer highly
27 gonorrhoeae and Chlamydia trachomatis using nucleic acid amplification tests detects greater numbers
28 of 3 algorithms that detect AHI based on HIV nucleic acid amplification testing (EarlyTest algorithm)
29 at first vaginal intercourse and a positive nucleic acid amplification test for sexually transmitted
30 ple, sample-to-answer, on-demand, multiplex, nucleic acid amplification test for syndromic diagnosis
31 Qiagen artus C. difficile QS-RGQ kit, a new nucleic acid amplification test for the detection of Clo
32 opment of an internally controlled multiplex nucleic acid amplification test for the detection of den
33 imens, a useful characteristic in the age of nucleic acid amplification testing for gonococcal infect
34 For all urine specimens, UA, culture, and nucleic acid amplification testing for Neisseria gonorrh
41 between liquid cytologic media and multiple nucleic acid amplification tests for the detection of C.
43 ree commercial identification kits and three nucleic acid amplification tests for the identification
45 ratory viral panel (eSensor RVP) multiplexed nucleic acid amplification test (GenMark Diagnostics, In
47 t MTB/RIF (Xpert), a novel, semiautomated TB nucleic-acid amplification test, has renewed interest in
50 strategies, newer testing methods, including nucleic acid amplification tests, have enhanced sensitiv
51 Emerging POC microbiology tests, especially nucleic acid amplification tests, have the potential to
52 FilmArray Respiratory Panel (RP) multiplexed nucleic acid amplification test (Idaho Technology, Inc.,
54 f C. trachomatis- or N. gonorrhoeae-specific nucleic acid amplification testing in this metropolitan
55 n will expand the diagnostic applications of nucleic acid amplification tests, in particular for near
56 This work presents an on-chip isothermal nucleic acid amplification test (iNAAT) for the multiple
57 that evaluated 1 of 3 commercially available nucleic acid amplification tests, included data from tes
58 the introduction of diagnostic M. genitalium nucleic acid amplification testing including antimicrobi
60 dia trachomatis and Neisseria gonorrhoeae by nucleic acid amplification tests is an attractive altern
62 Here we report the development of a mobile nucleic acid amplification testing (mobiNAAT) platform u
63 utility of Mycobacterium tuberculosis direct nucleic acid amplification testing (MTD) for pulmonary t
64 sitive for stx by an alternative FDA-cleared nucleic acid amplification test (NAAT) but were negative
65 2) is a Food and Drug Administration-cleared nucleic acid amplification test (NAAT) for the detection
68 atis or N. gonorrhoeae, two or more positive nucleic acid amplification test (NAAT) results, or a sin
69 seria gonorrhoeae (gonococcus [GC])-positive nucleic acid amplification test (NAAT) results: (i) repe
71 s and symptoms, in contrast with only 3 of 8 nucleic acid amplification test (NAAT)-based studies (P
72 sistant tuberculosis (MDR-TB) screening, all nucleic acid amplification test (NAAT)-positive respirat
74 rator for improving the harmonization of BKV nucleic acid amplification testing (NAAT) and enabling c
75 tion of Chlamydia trachomatis were tested by nucleic acid amplification testing (NAAT) and in cell cu
76 We evaluated criteria to reduce unnecessary nucleic acid amplification testing (NAAT) for viral path
80 virus infection (AHI); however, the cost of nucleic acid amplification testing (NAAT) makes individu
81 onreactive samples were pooled and tested by nucleic acid amplification testing (NAAT) to identify ac
84 chomatis infection in certain populations by nucleic acid amplification testing (NAAT), as they invol
87 testing practices since the introduction of nucleic acid amplification tests (NAAT), we surveyed lab
89 sts (wet mount, culture, a rapid test, and a nucleic acid amplification test [NAAT]) were performed o
90 igenic organisms (toxigenic culture [TC] and nucleic acid amplification testing [NAAT]) are confounde
92 lty of culture of this fastidious bacterium, nucleic acid amplification tests (NAATs) are necessary f
95 ning from toxin enzyme immunoassays (EIA) to nucleic acid amplification tests (NAATs) as the primary
98 suggested approaches for confirming positive nucleic acid amplification tests (NAATs) for Chlamydia t
100 cent sexual assault survivors include use of nucleic acid amplification tests (NAATs) for detection o
101 is study was to determine the added value of nucleic acid amplification tests (NAATs) for detection o
103 rapid development of commercially available nucleic acid amplification tests (NAATs) for influenza v
104 r, the true limitation in the realization of nucleic acid amplification tests (NAATs) for near-patien
105 udy evaluated the performance of culture and nucleic acid amplification tests (NAATs) for rectal chla
108 was to define the performance of culture and nucleic acid amplification tests (NAATs) for the diagnos
110 self-obtained vaginal specimens processed by nucleic acid amplification tests (NAATs) has significant
112 ple, recent studies with ribosomal RNA-based nucleic acid amplification tests (NAATs) have demonstrat
115 DTs), digital immunoassays (DIAs), and rapid nucleic acid amplification tests (NAATs) in children and
116 a CT (ACT) (Hologic Inc., San Diego, CA) are nucleic acid amplification tests (NAATs) that detect Chl
117 . Food and Drug Administration (FDA)-cleared nucleic acid amplification tests (NAATs) to culture usin
120 ribing the diagnostic performance of malaria nucleic acid amplification tests (NAATs) using these spe
121 , and illumigene group B Streptococcus (GBS) nucleic acid amplification tests (NAATs) were compared t
123 ests for Chlamydia trachomatis have compared nucleic acid amplification tests (NAATs) with diagnostic
129 ave developed an economical, high-throughput nucleic acid amplification test (NAT) for blood-borne vi
130 ccepted for transplantation.Universal use of nucleic acid amplification testing (NAT) for the screeni
134 ions and the incremental yield and safety of nucleic acid amplification tests of individual donations
135 rmed to be positive for HIV-1 and HCV RNA on nucleic acid-amplification testing of "minipools" (pools
138 retrospectively using enzyme immunoassay and nucleic acid amplification tests on stored specimens.
139 defined as a confirmed positive result on a nucleic acid amplification test or as HIV antibody seroc
141 ymptomatic sexual health screening underwent nucleic acid amplification testing; positive samples and
142 specimens, known to be gonorrhea positive by nucleic acid amplification testing, provided by females
143 Screening of broth enrichment fluids by nucleic acid amplification testing requires careful hand
145 treatment failure determined on the basis of nucleic acid amplification testing, sexual history, and
147 In many clinical microbiology laboratories, nucleic acid amplification tests such as PCR have become
150 y have residual DNA in sputum that confounds nucleic acid amplification tests such as Xpert MTB/RIF.
151 ulture-based systems, simplified versions of nucleic acid amplification tests (such as the Xpert MTB/
153 le virus RNA with the use of investigational nucleic acid amplification tests; testing was performed
154 With a reference standard of two different nucleic acid amplification tests, the sensitivity and sp
155 erpretation of gonorrhea tests of cure using nucleic acid amplification testing, this study examined
157 tly, some laboratories have begun adding HIV nucleic acid amplification testing to HIV diagnostic tes
159 lection agencies implemented West Nile virus nucleic acid-amplification tests to identify infected do
160 est yield on minipool testing, retrospective nucleic acid amplification testing was performed on indi
161 dictive value of the algorithm that included nucleic acid amplification testing were greater than 0.9
162 e respective rates of positive HCV and HIV-1 nucleic acid-amplification tests were 3.3 and 4.1 times
163 acutely viremic blood donors, identified by nucleic acid amplification testing, were enrolled and mo
164 The Xpert MTB/RIF (Xpert) assay is a rapid nucleic acid amplification test widely used in settings
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。